Clinical Trial Update: Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) [Phase 2]

View source ↗

Summary

The CAPTUR Phase 2 trial by the Canadian Cancer Trials Group is currently recruiting and evaluates profiling and targeted agent utilization in non-Hodgkin lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma
• Solid Tumors

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Lymphoma, Non-Hodgkin, Multiple Myeloma | Phase 2 | Status: RECRUITING